| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.564 | 87.535 | 158.644 | 186.961 | 185.951 | 158.204 | 194.182 | 224.895 | 197.463 | 223.494 |
| Total Income - EUR | 27.566 | 87.616 | 158.652 | 197.706 | 185.951 | 163.446 | 195.092 | 229.090 | 207.023 | 227.238 |
| Total Expenses - EUR | 30.206 | 116.946 | 170.158 | 195.476 | 176.506 | 151.677 | 172.869 | 193.361 | 179.205 | 210.571 |
| Gross Profit/Loss - EUR | -2.640 | -29.330 | -11.506 | 2.230 | 9.445 | 11.769 | 22.223 | 35.729 | 27.817 | 16.667 |
| Net Profit/Loss - EUR | -3.467 | -30.205 | -13.093 | 253 | 7.585 | 10.267 | 20.281 | 33.525 | 26.139 | 14.400 |
| Employees | 5 | 9 | 10 | 10 | 9 | 8 | 8 | 6 | 6 | 6 |
Check the financial reports for the company - Zopideloma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 688 | 202 | 652 |
| Current Assets | 45.784 | 74.579 | 47.698 | 48.283 | 46.240 | 61.018 | 79.556 | 59.033 | 63.790 | 92.654 |
| Inventories | 35.534 | 60.923 | 45.015 | 45.532 | 42.965 | 47.364 | 59.396 | 49.878 | 57.871 | 76.092 |
| Receivables | 10.188 | 12.916 | 2.507 | 2.350 | 2.511 | 3.019 | 2.729 | 4.264 | 3.032 | 3.195 |
| Cash | 62 | 740 | 176 | 400 | 764 | 10.634 | 17.432 | 4.891 | 2.887 | 13.368 |
| Shareholders Funds | -3.422 | -33.592 | -46.116 | -45.017 | -36.560 | -25.600 | -4.752 | 28.759 | 54.810 | 68.904 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 49.205 | 108.171 | 93.815 | 93.301 | 82.800 | 86.618 | 84.308 | 30.963 | 9.181 | 31.500 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Zopideloma Srl